Download Your Complimentary Copy of the Agenda
The inaugural Muscular Disorders Drug Development Summit is your industry-led forum to learn, network and partner with the experts innovating novel therapeutics for muscular dystrophies, Pompe disease and related myopathies.
Covering the Full Spectrum of Muscular Disorders Drug Development
From Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD) to myotonic dystrophy (DM1), limb-girdle muscular dystrophy (LGMD), Pompe disease, and related myopathies, the Muscular Disorders Drug Development Summit brings together leaders driving innovation across the muscular disease landscape. Explore shared development challenges, indication-specific insights, and opportunities to accelerate therapeutic advancement across multiple disease areas.
Attending Companies Include
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
60+
Industry-Based Attendees in a Targeted Environment
18+
Expert Speakers Spanning Biotech, Pharma & Investor Perspectives
8+
Hours of Dedicated Networking with the Muscular R&D Community
3
Days of Data-Driven Insights Spanning a Range of Modalities & Myopathies
2
Interactive Workshops Tacking Translational & Clinical Challenges